Brillanz Pharma Private Limited

Brillanz Pharma Private Limited - pharma in Kamothe, Maharashtra, India. FY 2026 financials and compliance.
CIN U74999MH2017PTC290928 Incorporated 08 February 2017 ROC Mumbai HQ Kamothe, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹1.94 Lakh
▼ 59.00% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
9 yrs
Est. 2017
Last financials
Mar 2023
Balance sheet date

About Brillanz Pharma Private Limited

Data last updated: 04 February 2026

Brillanz Pharma Private Limited is a private limited company based in Kamothe, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 08 February 2017, the company has been in operation for over 9 years.

Registered with ROC Mumbai under CIN U74999MH2017PTC290928.

Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prannoti Hemant Mote and Deepali Manoj Tarate.

Last AGM: 28 September 2023. Financial statements filed for year ended 31 March 2023. Office: Fl – D/303 Satyakunj Com Plot No.41&42 Sector – 3, Kamothe, Maharashtra, India – 410209.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.94 Lakh, a decline of 59% compared to the previous year.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Brillanz Pharma Private Limited
CIN U74999MH2017PTC290928
Registration Number 290928
Incorporation Date 08 February 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Fl – D/303 Satyakunj Com Plot No.41&42 Sector – 3, Kamothe, Maharashtra, India – 410209
  • Industry
    Pharma, Drug Formulation & Development
Company report
Brillanz Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Brillanz Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Brillanz Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Brillanz Pharma Private Limited

Brillanz Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Brillanz Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Brillanz Pharma Private Limited

Brillanz Pharma Private Limited is audited by A V PARMAR & ASSOCIATES for the financial year 2018. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
A V PARMAR & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Brillanz Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Brillanz Pharma Private Limited

Brillanz Pharma Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Prannoti Hemant Mote Director 08 Feb 2017 9 Years 5 Months Current
Deepali Manoj Tarate Director 08 Feb 2017 9 Years 5 Months Current

Financials of Brillanz Pharma Private Limited FY 2023 filings available

Brillanz Pharma Private Limited reported revenue of ₹1.94 Lakh (down 59.00% YoY) for FY 2023.

Revenue · FY 2023
₹1.94 Lakh ▼ 59.00%
Premium access

Ten-year financial statements for Brillanz Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Brillanz Pharma Private Limited

Premium access

Shareholding and ownership data for Brillanz Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Brillanz Pharma Private Limited

Brillanz Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Brillanz Pharma Private Limited

View historical data on people associated with Brillanz Pharma Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Brillanz Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Brillanz Pharma Private Limited

Premium access

GST registrations and filing compliance for Brillanz Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Brillanz Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Brillanz Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Brillanz Pharma Private Limited

Premium access

MSME payment history for Brillanz Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Brillanz Pharma Private Limited

Premium access

Corporate group structure for Brillanz Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Brillanz Pharma Private Limited

Premium access

MCA filings and documents for Brillanz Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Brillanz Pharma Private Limited

Activity
28 Sep 2023
Brillanz Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2023 as per latest MCA records.
Activity
31 Mar 2023
Brillanz Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Directors
08 Feb 2017
Prannoti Hemant Mote was appointed as a Director on 08 Feb 2017 & has been associated with this company since 9 years 5 months.
Directors
08 Feb 2017
Deepali Manoj Tarate was appointed as a Director on 08 Feb 2017 & has been associated with this company since 9 years 5 months.
Activity
08 Feb 2017
Brillanz Pharma Private Limited was registered on 08 Feb 2017 with Roc Mumbai & aged 9 years 5 months as per MCA records.

Frequently Asked Questions about Brillanz Pharma Private Limited

Brillanz Pharma Private Limited is an active private limited company in the pharma sector based in Kamothe, Maharashtra, India. It was incorporated on 08 February 2017 (9+ years old) and is registered under CIN U74999MH2017PTC290928.

Brillanz Pharma Private Limited reported revenue of ₹1.94 Lakh for FY 2023 (down 59.00% YoY).

The current directors of Brillanz Pharma Private Limited are:

The primary industry of Brillanz Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Brillanz Pharma Private Limited can be reached at the registered office: Fl – D303 Satyakunj Com Plot No.41&42 Sector – 3, Kamothe, Maharashtra, India – 410209.

The authorised capital is ₹5 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available